Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
EzriCare Artificial Tears Lawsuit Indicates Exposure to Bacteria in Eye Drops Caused Vision Damage Lawsuit indicates EzriCare eye drop infection occurred months after an Artificial Tears recall over Pseudomonas aeruginosa contamination. May 5, 2023 Russell Maas Add Your Comments A California man has filed a lawsuit against the manufacturers of EzriCare Artificial Tears, alleging that exposure to Pseudomonas aeruginosa bacteria in the recalled eye drops caused him to develop a severe infection and permanent vision damage. The complaint (PDF) was filed by Jamie Foti in the U.S. District Court District Central District of California, Southern Division on May 3, claiming the manufacturers advertised the eye drop products as safe for use, while failing to thoroughly test the products for bacterial contamination. The case joins a growing number of EzriCare Artificial Tears lawsuits now being pursued by consumers nationwide, who have experienced Pseudomonas aeruginosa infections that have caused a wide range of health problems, including vision problems, bloodstream infections and death. A number of eyedrops class action lawsuits have also been filed against the manufacturers, seeking damages on behalf of all consumers who purchased the Artificial Tears products that were recalled in February 2023. EYE DROPS RECALL LAWSUITS Did you or a loved one use recalled eye drops? Lawyers are investigating EzriCare Artificial Tears lawsuits for individuals who experienced eye infections, blindness or other problems following use of the recalled eye drops. Learn More SEE IF YOU QUALIFY FOR COMPENSATION EYE DROPS RECALL LAWSUITS Did you or a loved one use recalled eye drops? Lawyers are investigating EzriCare Artificial Tears lawsuits for individuals who experienced eye infections, blindness or other problems following use of the recalled eye drops. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Artificial Tears Eye Drops Recall The EzriCare Artificial Tears recall was announced by the U.S. Food and Drug Administration (FDA) on February 2, when the agency warned that at least 55 individuals had suffered eye infections after exposure to bacteria in eye drops, with several resulting in permanent blindness and at least one death from a severe bloodstream infection. The recall impacted multiple versions of the lubricant eye drops sold in ½ fluid ounce (15 ml) bottles, including Artificial Tears packaged under the brand names EzriCare, as well as Delsam, with the following UPC and NDC codes; Ezricare (blue box): NDC 79503-0101-15 with UPC 3 79503 10115 7, and Delsam Pharma (white box): NDC 72570-121-15 with UPC -72570-0121-15 EzriCare Eye Infection Lawsuit According to the complaint, Foti purchased EzriCare’s Artificial Tears from a Walgreens in Santa Ana, California, where he began to use the products routinely for relief of dry and itching eyes. Foti’s states that shortly after beginning use of the eye drops on March 1, 2023, he began to experience irritation, swelling, extreme pain and discomfort in the eyes and skull, sensitivity to light, sensitivity to touch, blurred vision, ultimately causing him to be hospitalized. As a result of the exposure to the contaminated EzriCare eye drops, Foti states he has been left with permanent eye and vision damage, aggravation of a pre-existing condition and has accumulated expenses from being hospitalized and needing medical and nursing care treatments. While the U.S. Centers for Disease Control and Prevention issued a warning about a multi-state outbreak of a rare strain of Pseudomonas Aeruginosa eye infections linked to the use of artificial tears products, Foti states that he was unaware of the warning at the time he started using the contaminated eye drops. The lawsuit brings claims of product liability, design and manufacturing defects, failure to warn, fraudulent concealment and gross negligence, demanding a jury trial to seek damages in excess of $75,000. Lawyers Reviewing EzriCare and Delsam Pharma Eye Drop Lawsuits As the news about the recalled EzriCare and Delsam Pharma eye drops continues to spread, it is expected that the number of Pseudomonas aeruginosa infection lawsuits over the recalled eye drops will be filed in the coming months. Lawyers are actively investigating potential eye drop infection lawsuits against the manufacturers and distributors of EzriCare and Delsam Pharma’s eye drops for multiple injuries and side effects caused by the contamination, including; Eye Infection Partial Blindness Permanent Blindness Bloodstream Infection Other injuries caused by the eye drops FIND OUT IF YOU HAVE AN EZRICARE LAWSUIT Submit information about problems experienced after exposure to bacteria in Artificial Tears eye drops to determine whether you or a loved one may be eligible to pursue an EzriCare lawsuit settlement. FIND OUT IF YOU ARE ELIGIBLE Tags: Bacterial Contamination, Eye Drops, Eye Drops Recall, EzriCare Eye Drops, Infection, Pseudomonas Aeruginosa, Vision Loss Image Credit: | More Eye Drops Recall Lawsuit Stories Lawsuit Alleges Infection From Recalled Eye Drops Caused Permanent Vision Damage, Light Sensitivity July 8, 2024 Eye Drops Vision Damage Lawsuit Filed Over Bacteria in Recalled Artificial Tears June 7, 2024 Amazon Artificial Tears Lawsuit Filed Over Bacterial Keratitis Infection from Contaminated Eye Drops February 15, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Lawsuit Alleges Infection From Recalled Eye Drops Caused Permanent Vision Damage, Light Sensitivity July 8, 2024
Amazon Artificial Tears Lawsuit Filed Over Bacterial Keratitis Infection from Contaminated Eye Drops February 15, 2024
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)